Please activate JavaScript!
Please install Adobe Flash Player, click here for download
ePaper created 2014-09-15, 12:31:02 | version 1.32.01
References 1. Heydendael VMR, Spuls PhI, Opmeer BC, et al. Methotrexate versus cyclosporine in moderate to severe chronic plaque psoriasis. N Eng J Med 2003; 349: 658-65. 2. Pathirana D. Ormerod A. D. Saiag P. et al. European S3-guidelines on the systemic treatment of psoriasis vulgaris. J Eur Acad Dermatol 2009; 23: 1-70. 3. Vries ACQ de, Bogaards NA, Hooft L, et al. Interventions for nail psoriasis. Cochrane Database of Systematic reviews 2013, Issue 1. Art. No.: CD007633. DOI: 10. 1002/14651858.CD007633.pub2. 4. Schram ME, Roekevisch E, Leeflang MM, er al. A randomized trial of methotrexate versus azathioprine for severe atopic eczema. J Allergy Clin Immunol 2011: 128: 353-9. 5. Spuls PI, Lecluse LL, Poulsen ML, et al. How Good Are Clinical Severity and Outcome Measures for Psoriasis?: Quantitative Evaluation in a Systematic Review. J Invest Dermatol 2010; 130: 933-43. 6. Prinsen CA, Lindeboom R, Korte J de. Interpretation of Skindex-29 scores: cutoffs for mild, moderate, and severe impairment of health-related quality of life. J Invest Dermatol 2011; 131: 1945-7. 7. Schmitt J, Spuls PhI, Boers M, et al. Towards global consensus on outcome measures for atopic eczema research: results of the HOME II meeting. Core outcome measures for atopic eczema research. Allergy 2012; 67: 1111-7. 8. Schmitt J, Langan S, Deckert S, et al. Assessment of clinical signs of atopic dermatitis: A systematic review and recommendation. J Allergy Clin Immunol 2013; 132: 1337-47. 47 Psoriasis of the toenails. BWEADVSMGFINCORR:Opmaak 1 21-07-2014 17:39 Pagina 47